Results 61 to 70 of about 1,664,993 (364)
Evolution of all-or-none strategies in repeated public goods dilemmas. [PDF]
Many problems of cooperation involve repeated interactions among the same groups of individuals. When collective action is at stake, groups often engage in Public Goods Games (PGG), where individuals contribute (or not) to a common pool, subsequently ...
Flávio L Pinheiro +3 more
doaj +1 more source
Research on Repeated Quantum Games with Public Goods under Strong Reciprocity
We developed a repeated quantum game of public goods by using quantum entanglement and strong reciprocity mechanisms. Utilizing the framework of quantum game analysis, a comparative investigation incorporating both entangled and non-entangled states ...
Simo Sun +3 more
doaj +1 more source
Communication and Cooperation in Repeated Games
We study the role of communication in repeated games with private monitoring. We first show that without communication, the set of Nash equilibrium payoffs in such games is a subset of the set ofε‐coarse correlated equilibrium payoffs (ε‐CCE) of the ...
Yu Awaya, V. Krishna
semanticscholar +1 more source
From repeated games to Brownian games [PDF]
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
openaire +3 more sources
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad +12 more
wiley +1 more source
Reactive Strategies: An Inch of Memory, a Mile of Equilibria
We explore how an incremental change in complexity of strategies (“an inch of memory”) in repeated interactions influences the sets of Nash equilibrium (NE) strategy and payoff profiles. For this, we introduce the two most basic setups of repeated games,
Artem Baklanov
doaj +1 more source
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg +43 more
wiley +1 more source
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Designing fair and sustainable pricing mechanisms for health insurance requires accurate risk assessment and the formulation of incentive-compatible strategies among stakeholders.
Saeed Shouri +2 more
doaj +1 more source

